Dinesh K. Kalra, M.D., MBA, FACC, FNLA, FSCCT, FSCMR, FAHA, FASPC
Dinesh K. Kalra, M.D., MBA, FACC, FNLA, FSCCT, FSCMR, FAHA, FASPC
- Professor of Medicine
- Chief, Division of Cardiovascular Medicine
- Vice Chair for Quality, Department of Medicine
- Jewish Hospital Cardiovascular Innovation Institute Director Chair in Medicine
- Director of Advanced Cardiac Imaging, Lipid Clinic & Infiltrative Heart Disease Program
401 East Chestnut Street, Ste. 310
Louisville, KY 40202
502-852-9505 - Academic Office
502-588-7010 - Patient Appointments
Clinical Expertise
General Cardiology; Vulnerable Atherosclerotic Plaque and Regression by CCTA; Cardiac MRI and CT; Lipidology; Novel Therapies and Advanced CMR Imaging in Pulmonary Hypertension
Board Certification
- American Board of Internal Medicine -
Cardiovascular Disease
Education and Training
- Medical School: All India Institute of Medical Sciences
- Residency: Baylor College of Medicine Affiliated Hospitals
- Fellowships: Baylor College of Medicine (Cardiology); University of Michigan (Electrophysiology); Weill-Cornell New York Presbyterian Hospital (Advanced Cardiac Imaging)
Get To Know Dr. Kalra
Featured Publications
- Duell PB, Mehta V, Wong ND, Kalra D, Vijayaraghavan K, Puri R. Management of diabetic dyslipidemia in South Asian patients: The need for individualized treatment guidelines. J Clin Lipidol. 2023 Apr 17:S1933-2874(23)00067-3. doi: 10.1016/j.jacl.2023.04.001. Epub ahead of print. PMID: 37117075.
- Pushpakumar S, Singh M, Zheng Y, Akinterinwa OE, Mokshagundam SPL, Sen U, Kalra DK, Tyagi SC. Renal Denervation Helps Preserve the Ejection Fraction by Preserving Endocardial-Endothelial Function during Heart Failure. Int J Mol Sci. 2023 Apr 15;24(8):7302. doi: 10.3390/ijms24087302. PMID: 37108465; PMCID: PMC10139195.
- Shah AJ, Beckmann T, Vorla M, Kalra DK. New Drugs and Therapies in Pulmonary Arterial Hypertension. Int J Mol Sci. 2023 Mar 19;24(6):5850. doi: 10.3390/ijms24065850. PMID: 36982922; PMCID: PMC10058689.
- Umer M, Kalra DK. Treatment of Fabry Disease: Established and Emerging Therapies. Pharmaceuticals (Basel). 2023 Feb 20;16(2):320. doi: 10.3390/ph16020320. PMID: 37259462; PMCID: PMC9967779.
- Umer M, Kalra DK. Cardiac MRI in Fabry disease. Front Cardiovasc Med. 2023 Feb 2;9:1075639. doi: 10.3389/fcvm.2022.1075639. PMID: 36818911; PMCID: PMC9931723.
- Apte N, Kalra DK. Pharmacotherapy in Ventricular Arrhythmias. Cardiology. 2023;148(2):119-130. doi: 10.1159/000529670. Epub 2023 Mar 6. PMID: 36878200.
- Umer M, Motwani M, Jefferies JL, Nagueh SF, Kalra DK. Cardiac Involvement in Fabry Disease and the Role of Multimodality Imaging in Diagnosis and Disease Monitoring. Curr Probl Cardiol. 2023 Jan;48(1):101439. doi: 10.1016/j.cpcardiol.2022.101439. Epub 2022 Oct 4. PMID: 36202174.
- Tyagi SC, Pushpakumar S, Sen U, Mokshagundam SPL, Kalra DK, Saad MA, Singh M. COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients. Int J Mol Sci. 2022 Dec 24;24(1):287. doi: 10.3390/ijms24010287. PMID: 36613731; PMCID: PMC9820572.
- Hermel M, Pelter M, Jordan T, Latif A, Gad MM, Slipczuk L, Kalra D, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress. Curr Atheroscler Rep. 2022 Dec;24(12):981-993. doi: 10.1007/s11883-022-01072-0. Epub 2022 Nov 8. PMID: 36346504; PMCID: PMC9641304.
- Gupta K, Al Rifai M, Hussain A, Minhas AMK, Patel J, Kalra D, Samad Z, Virani SS. South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent? Prog Cardiovasc Dis. 2022 Nov-Dec;75:21-32. doi: 10.1016/j.pcad.2022.10.001. Epub 2022 Oct 22. PMID: 36279943.
